A study in JAMA Internal Medicine suggests the use of continuous-cycle and extended-cycle combined oral contraceptives may not meaningfully increase a woman's risk of venous thromboembolism. Data showed slightly more blood clot-related hospitalizations in patients taking these oral contraceptives, compared with traditional cyclic contraceptives.
Research evaluates risks of oral contraceptives
Sign up for uPdaTe SmartBrief
News for physical therapists focused on women's health
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.